Announcement

20
SEPTEMBER
2018


Category Label


Client Announcements

Crimson Tide PLC : Contract Wins and Recruitment

  •  
  •   20 September 2018

RNS Number : 3166B

Crimson Tide PLC

20 September 2018

 

Crimson Tide plc

 

("Crimson Tide" or "the Company")

 

Contract Wins and Recruitment

 

Crimson Tide, the provider of mpro5 - smart mobility as a service (AIM: TIDE.L), announces a number of contract wins and updates the market on staff recruitment

 

The Company has signed its first subscription agreements in the Middle East with two clients. Both companies will be completing maintenance, engineering, and health & safety workflows on mpro5 and the Company is hopeful of more wins to come. The Company has hired Zyldxian Pereira as Middle East Sales Executive to pursue further opportunities across the region.

 

A contract has been won with a $20bn revenue US Pharma Company to provide a patient portal for one of its ground-breaking anti-cholesterol drugs. The Company has recruited Stephen Logue, most recently with Paypal to head up its sales effort in Ireland, where this business was agreed.

 

The Company is also pleased to announce that Sam Roberts has agreed to re-join the Company as Director of Enterprise Sales after a period at Samsung, where he headed the sales relationship with O2.

 

 

 

Barrie Whipp, Executive Chairman, commented,

 

"It is very encouraging to win these new contracts, which demonstrate mpro5's capabilities in exciting areas. We are also happy to add to our sales team and I am extremely pleased to welcome Sam back to Crimson Tide. "

 

 

 

Enquiries:

 

Crimson Tide plc                          

Barrie Whipp / Luke Jeffrey

 

01892 542444

Arden Partners

Steve Douglas / Dan Gee-Summons

 

020 7614 5900

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAEKLFFVKFEBBZ

;